 |
 |

Treatment of Frey Syndrome With Botulinum Toxin Type F
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
We are writing in regard to the article by Vargas et al1
entitled "A Pilot Study Evaluating the Treatment of Postparotidectomy Sialoceles
with Botulinum Toxin Type A [BoNT/A]," which was published in the March 2000
issue of the ARCHIVES. In accordance with the experience of Vargas and colleagues,
my coworkers and I recently reported our results using BoNT/F to treat a parotid
sialocele.2 Therefore, we believe that BoNT
serotypes other than type A should be considered for use in patients who do
not respond to treatment with BoNT/A. In 1995, Drobik and Laskawi3 suggested using BoNT/A to treat patients affected
by gustatory sweating, or Frey syndrome. The goal was the reduction of facial
sweating by the determination of a cholinergic autonomic block.
Different BoNT serotypes have been used to treat muscles of patients
with immunoresistance to BoNT/A,4, 5, 6
but, to our knowledge, the use of BoNT serotypes other than BoNT/A has . . . [Full Text of this Article]
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|